USPTO serial 79237945
Reviewed by CopyMark Law Group
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey B. Sladkus, Esq.
Jeffrey B. Sladkus, Esq. The Sladkus Law Group1397 Carroll DriveAtlanta, GA 30318UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products excluding surgical implants comprising living tissue, namely, pharmaceutical products comprised of adipose tissue, adipose stem cells and progenitor cells for use in plastic and reconstructive surgery and human regenerative medicine; veterinary products excluding surgical implants comprising living tissue, namely, adipose tissue, adipose stem cells and progenitor cells; chemical preparations comprised of adipose tissue, adipose stem cells and progenitor cells for medical use and pharmaceutical use | ACTIVE | — |
| 010 | Surgical apparatus and instruments for collecting adipose tissue and purifying cells, excluding implants; medical apparatus and instruments for collecting adipose tissue and purifying cells, excluding implants; veterinary apparatus and instruments for collecting adipose tissue and purifying cells, excluding implants | ACTIVE | — |
| 044 | Medical services relating to therapeutic solutions in the fields of plastic and reconstructive surgery and human regenerative medicine, using adipose tissue and progenitor cells, excluding implants; medical consultation; plastic surgery relating to therapeutic solutions by using adipose tissue and progenitor cells, excluding implants; hospital services relating to therapeutic solutions by using adipose tissue and progenitor cells, excluding implants; alternative medicine services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 30, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 14, 2020 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 26, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 25, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 24, 2020 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 8, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 8, 2020 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 25, 2019 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 25, 2019 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 26, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 26, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 26, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 4, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 28, 2019 | ALIE | ASSIGNED TO LIE | — |
| Feb 25, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 15, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 24, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 24, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 15, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 14, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 11, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 7, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 7, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 6, 2018 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Aug 2, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |